Abstract
Chronic obstructive pulmonary disease (COPD) combined with malnutrition results in decreased exercise capacity and a worse quality of life. We aimed to develop an observational case–control study to explore the effective and convenient method to identify potential individuals is lacking. This study included data from 251 patients with COPD and 85 participants in the control group. Parameters and body composition were compared between groups, and among patients with varied severity. The LASSO approach was employed to select the features for fitting a logistic model to predict the risk of malnutrition in patients with stable COPD. Patients with COPD exhibited significantly lower 6-min walk distance (6MWD), handgrip strength, fat-free mass index (FFMI), skeletal muscle mass (SMM) and protein. The significant predictors identified following LASSO selection included 6MWD, waist-to-hip ratio (WHR), GOLD grades, the COPD Assessment Test (CAT) score, and the prevalence of acute exacerbations. The risk score model yielded good accuracy (C-index, 0.866 [95% CI 0.824–0.909]) and calibration (Brier score = 0.150). After internal validation, the adjusted C-index and Brier score were 0.849, and 0.165, respectively. This model may provide primary physicians with a simple scoring system to identify malnourished patients with COPD and develop appropriate rehabilitation interventions.
Similar content being viewed by others
Introduction
Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable chronic respiratory disease characterized by persistent respiratory symptoms and airflow limitation1. Growing evidence suggests that COPD is associated with various extrapulmonary effects, including changes in nutritional status and body composition2. Previous studies showed that the incidence of malnutrition in patients with COPD was 30–60%3,4, leading to reduced exercise tolerance, higher risk of acute exacerbations and lower quality of life. Previous experts have used body mass index (BMI) less than 20 kg/m2 as a diagnostic criterion for malnutrition5, however, it is important to note that BMI may not accurately capture the nuanced alterations in an individual's body composition. Therefore, this observational case–control study combined fat-free mass index (FFMI) to assess the nutritional status of stable COPD with the body composition analyzer and explored the correlation between FFMI with pulmonary function indices, exercise capacity and clinical symptoms. To effectively implement early intervention strategies aimed at delaying the progression of deterioration, we also constructed a prediction model for recognizing patients that probably combined with malnutrition.
Methods
Study population
Our study recruited 251 male outpatients with stable COPD from October 2019 to December 2021 at the First Affiliated Hospital of Soochow University diagnosed according to the Global Initiative for Chronic Obstructive Lung Disease. Another 85 healthy participants during the same period were also included as the control group. They were randomly recruited by posting flyers on bulletin boards as well as from data collected at the hospital. Informed consent was obtained from all subjects and this study was approved by the research ethics committee of the first hospital affiliated to Soochow university (NO. 2022088).
Information collection
We collected the demographic and clinical characteristics of all participants, including their age, height, weight, history of smoking, acute exacerbations during the past year, and evaluation of symptoms with the COPD Assessment Test (CAT) and Modified British Medical Research Council (mMRC).
All the enrolled patients underwent spirometry using a Master screen-PFT system (Vyaire, Mettawa, Ill, USA) in the Pulmonary Function Test Room, and the forced expiratory volume during one second (FEV1) and forced vital capacity (FVC) were measured, according to the American Thoracic Society (ATS) consensus guidelines6. The FEV1, FEV1/FVC, and the ratio of FEV1 to predicted FEV1(FEV1%) after inhaling bronchodilators were recorded. According to the category of airflow limitation in COPD (based on FEV1 after the administration of a bronchodilator) in patients with FEV1/FVC < 0.70, stable COPD was divided into four GOLD grades: mild (GOLD 1), ≥ 80% of predicted FEV1; moderate (GOLD 2), 50–80% of predicted FEV1; severe (GOLD 3), 30–50% of predicted FEV1; very severe (GOLD 4), < 30% of predicted FEV1. 6-min walk test was performed according to guideline at the time of inclusion by investigator7. Meanwhile, the participants' handgrip strength was measured with a WCS-100 electronic handgrip dynamometer (produced by Shanghai Yilian Science and Education Equipment Co., LTD.), with the maximum value of the dominant hand recorded.
Body composition was assessed using a BCA-2A bioelectrical impedance body composition analyzer (Tsinghua Tongfang Co., Ltd., Beijing, China) by specialized technician in the mean time. Body weight, waist-to-hip ratio (WHR), fat-free mass (FFM), fat mass (FM), muscle mass, skeletal muscle mass (SMM), visceral fat area (VFA) and other body composite variables were measured. The FFMI was calculated as the FFM/(height)2. According to the European Society for Clinical Nutrition and Metabolism (ESPEN)8, individuals with a BMI below 20 kg/m2 if they are under 70 years of age, or below 22 kg/m2 if they are 70 years of age or older, or a FFMI below 17 kg/m2 in males, were classified as having malnutrition.
Variables selection and construction of nomogram
We developed the risk-prediction model for the occurrence of malnutrition in stable COPD patients following the transparent reporting of a multivariable-prediction model for Individual Prognosis or Diagnosis guidelines9. The variables included patients’ age, handgrip strength, 6-min walk distance (6MWD), WHR, acute exacerbations during the past year, the history of smoking, CAT scores, FVC and FEV1%. We log-transformed values of WHR that was not normally distributed for inclusion in the model. 6MWD was converted into categorical variables, and the roc curve was used to determine the optimal cut-off. Besides, we used a restricted cubic spline to flexibly model and verify the linear relationship between continuous variable and outcome. After transforming, the least absolute shrinkage and selection operator (LASSO) method was taken for variable selection in the training set. In the LASSO approach, the value of λ is used to penalize the absolute magnitude of a regression model's coefficients. The estimates approach zero more as the penalty is increased. As a result, irrelevant variables have zero coefficients, which can be used to eliminate non-influential predictors from the final model10.
The model was developed based on the selected features and refitted to avoid model overfitting. A nomogram was then constructed by using a linear combination of the selected features weighted by their regression coefficients. "Points" indicates the score of the corresponding factor below and "Total Points" indicates the summation of all the scores of factors above.
The discriminative ability of the nomogram was evaluated by using Harrell's concordance index (C-index), which was analogous to the area under the receiver operating characteristic curve (AUC). Further, a calibration curve was plotted and the Brier score was calculated to evaluate the agreement between the predicted and actual risk. When the Brier score ≤ 0.25, the model was considered to have favorable calibration. Internal validity and adjustment for overfitting of the nomogram were implemented with a bootstrap resampling (100 times) analysis.
Statistical analysis
Continuous variables were expressed as mean standard deviation or median interquartile range, while categorical values were expressed using relative frequencies and proportions. Comparisons of parameters between 2 different groups were conducted with the t-test and the Mann–Whitney U test for continuous variables with or without normal distribution. Categorical variables were evaluated using the chi-square test or Fischer exact test. Data were analyzed using SPSS software (Version 24.0), and R software (Version 4.1.0). A p-value < 0.05 was considered statistically significant.
Results
This study included 251 male stable COPD cases in the COPD group and 85 cases in the control group. As shown in Table 1, COPD patients presented significantly lower BMI, 6MWD, handgrip strength, FFMI, SMM, protein, and inorganic salt and mostly had a smoking habit (Table 1).
There were significant differences in age, weight, AE during the past year, CAT, mMRC, BMI, and skeletal muscle mass among different COPD grades when COPD patients were divided into four subgroups based on the FEV1% (Table 2). Compared with Grade I and II patients, Grade III and IV patients showed lower handgrip and 6MWD. The incidence of malnutrition corresponding to grades I, II, III, and IV was 30.86%, 36.36%, 63.49%, and 73.68% respectively.
All clinical variables were included in the LASSO method selection to construct a prediction model with our cohort. The most regularized and parsimonious model with a tuning λ (log scale) giving a cross-validated error within one standard error of the minimum included 5 significant variables. The results of multivariable logistic analysis were shown in Table 3.
A nomogram was constructed using the results to estimate the risk of malnutrition for patients with COPD (Fig. 1). Clinical scores were assigned to the 5 independent factors and the estimated risk of progression was calculated by summing the scores of each factor. The final score ranged from a minimum of zero points to a maximum of 300 points, where a straight line is drawn to determine the probability of response. This score-based nomogram allowed for a manual estimation of the cumulative risk of malnutrition for each patient. For example, a stable COPD patient with waist-hip ratio measured as 0.88 and finished the 6MWD test at 450 m. He underwent twice exacerbations over the last year, his baseline FEV1% was 45.3% with CAT score evaluated as 18. The total score was about 167, indicating that his risk of malnutrition was approximately 50%.
Our model presented very good discrimination (C-index, 0.866 [95% CI 0.824–0.909]) and calibration (Brier score = 0.150). After bootstrap validation (100 repetitions), the corrected C-index and Brier score were 0.849, and 0.165, respectively. The calibration curve (Fig. 2) showed good agreement between actual and predicted probabilities, and a bootstrap procedure (100 repetitions) provided a bias-corrected estimate of the calibration curve (mean absolute error = 0.042). The DCA curve utilized to evaluate the clinical utility of the nomogram is plotted in Fig. 3. It showed that intervening on patients on the basis of the prediction model leads to higher benefit than the alternative strategies of treating all patients. To evaluate the clinical effects of the nomogram model more visually, the CIC curve (Fig. 4) on the ground of DCA curve was drawn. The “Number high risk” curve was closely to the “Number high risk with event” curve, which indicated that the nomogram model owns extraordinary predictive power.
Discussion
The results of this study suggested that malnutrition was more common in COPD patients than in controls and got worse with the aggravation of airflow restriction. We enrolled 251 stable COPD patients to investigate the factors correlated with malnutrition. 6MWD, WHR, GOLD grades, AE and CAT score were significant predictors of complication of malnutrition after multivariable analysis. Finally, a nomogram was constructed to visually predict the risk of malnutrition in COPD patients with the basic clinical characteristics.
As shown in our study, the overall proportion of malnutrition in patients with stable COPD is 44.2%, which is in accordance with 30–60% worldwide3,4. 6-min walking test and grip strength are experiments used to roughly evaluate the exercise capacity of COPD patients in community practice. Previous studies11 showed that 6MWD was associated with pulmonary function parameters including FEV1% pred, FEV1/FVC, PEF and VC in patients with severe and very severe COPD. This study showed that the stable COPD patients’ activity tolerance was significantly lower than that of the control group. Furthermore, there was a substantial difference in skeletal muscle atrophy between COPD patients and healthy controls, aligning with the findings of van de Bool et al.12 that the proportion of muscle fibers were decreased in patients with COPD. Several reasons may account for the decline in skeletal muscle occurring in patients with COPD. The primary cause of rapid muscle mass and strength decline is an excessive breakdown of protein, often accompanied by a decrease in protein synthesis, as demonstrated in our study13. The systemic inflammatory response of COPD patients leads to peripheral muscle dysfunction14, with the type of muscle fibers shifted, resulting in worse muscle strength15. Furthermore, it has been observed that chronic hypoxia in patients with COPD can activate mediators that leads to a decrease in the oxygen content and a reduction in the capacity for oxygen transport. These physiological changes might subsequently result in alterations to the structure of the muscles16. Meanwhile, the dyspnea symptoms limit patients' exercise, which in turn leads to muscle atrophy and decreased exercise capacity17.
With the aggravation of COPD severity classified by GOLD grades, the patients' body weight, BMI, FFMI and SMM were all on a decreasing trend. The probability of combined malnutrition in COPD patients is significantly higher in grades III and IV, along with the decrease in exercise capacity. According to a related study, VFA > 100 cm2 was used as a threshold value to compare visceral fat area in patients with different stages of COPD and suggested that moderate-to-severe COPD patients had excessive visceral fat18. Although the difference was not statistically significant, we also observed the increase in severe COPD patients. This phenomenon may have something to do with the pronounced decline in skeletal muscle mass of the patients but is also related to the abnormal metabolic states and comorbidities of hypertension or diabetes. Malnutrition and excessive body fat19 are both harmful to the physical function and risk of cardiovascular disease for elderly patients.
Hence, the recognition and alleviation of muscle atrophy appears as a significant therapeutic target. As community healthcare plays a pivotal role in managing chronic condition while limited by equipment, the identification of malnutrition in patients with COPD holds significant therapeutic value. The strengths of this study include its status as a pioneer in developing and validating the first nomogram based on the Chinese clinical population by using a LASSO logistic model. According to our findings, 6MWD, waist-to-hip ratio, GOLD grades, CAT score and acute exacerbations during the past year were effective in predicting the risk of combined malnutrition. Airflow obstruction in COPD patients was significantly worse in the malnourished group than in the nutritionally normal group20,21, which is in line with previous study presented that FFMI has a positive association with FEV1% and FEV1/FVC22,23. Exacerbations in COPD patients are associated with decrease in fat-free mass24 and accelerated skeletal muscle loss25. Increased airflow limitation and exacerbations in patients lead to increased symptoms of dyspnea and higher CAT values, which in turn impair exercise capacity and affect patients’ quality of life26. Past studies measured handgrip to judge muscle mass27, while the relationship between exercise capacity and malnutrition remains uncertain. Our results revealed that 6MWD and handgrip strength were strongly correlated with skeletal muscle mass and nutritional status.
The predictors also suggested that augmenting the frequency of exercise sessions and improving patients' muscle strength, along with implementing nutritional interventions to alleviate dyspnea symptoms and enhance lung function, can effectively reduce the risk of combined malnutrition in stable COPD patients. Except for taking inhaled medications regularly, pulmonary rehabilitation is the most widely available, recommended intervention in persons with skeletal muscle dysfunction28. This nomogram showed satisfied discrimination and calibration performance in predicting malnutrition in COPD patients. It provides clinicians with scientific guidance and convenient approaches to identify individuals at high risk of malnutrition, thus intervening properly to improve patients’ quality of life and long-term prognosis.
However, some limitations of this study should be mentioned. This retrospective and single-centered study leads to potential selection bias, and only internal verification is shown. Considering the lower prevalence of COPD in females, we only included male participants. The results were incomplete since men's body composition differed from women's, especially in menopausal women. Future studies with larger sample sizes in multiple centers and longer follow-up periods should be conducted to confirm the accuracy of the currently observed relevant indicators. Recent researches have focused on the oxidative stress biomarkers and revealed that advanced oxidation protein products17, total radical trapping antioxidant parameter29 and resistin30 were signicant biomarkers related to sarcopenia in COPD. More serological markers need to be included and confirmed by further research.
Conclusion
This study demonstrated the nutritional status and functional exercise capacity of patients with stable COPD. As the disease worsens, the proportion of malnutrition increases and the muscle shows a declining trend. To identify malnutrition early and convenient, the study developed a prediction score system to distinguish people at high risk of malnutrition and conduct rehabilitation program. The model has good internal validity and high discrimination, providing great clinical value for potential promotion.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Xu, X. et al. The heterogeneity of inflammatory response and emphysema in chronic obstructive pulmonary disease. Front. Physiol. 12, 783396 (2021).
Bolton, C. E. et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 170, 1286–1293 (2004).
Ter Beek, L. et al. Dietary resilience in patients with severe COPD at the start of a pulmonary rehabilitation program. Int. J. Chronic Obstruct. Pulmon. Dis. 13, 1317–1324 (2018).
Dubé, B.-P. & Laveneziana, P. Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD. J. Thorac. Dis. 10, S1355–S1366 (2018).
Cao, C. et al. Body mass index and mortality in chronic obstructive pulmonary disease: A meta-analysis. PLoS ONE 7, e43892 (2012).
American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am. Rev. Respir. Dis. 144, 1202–1218 (1991).
Holland, A. E. et al. An official European Respiratory Society/American Thoracic Society technical standard: Field walking tests in chronic respiratory disease. Eur. Respir. J. 44, 1428–1446 (2014).
de Araújo, B. E., Kowalski, V., Leites, G. M., da Silva Fink, J. & Silva, F. M. AND-ASPEN and ESPEN consensus, and GLIM criteria for malnutrition identification in AECOPD patients: A longitudinal study comparing concurrent and predictive validity. Eur. J. Clin. Nutr. 76, 685–692 (2022).
Collins, G. S., Reitsma, J. B., Altman, D. G. & Moons, K. G. M. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. Br. J. Cancer 112, 251–259 (2015).
Tibshirani, R. Regression shrinkage and selection via the lasso. J. R. Stat. Soc. B 58, 267–288 (1996).
Chen, H. et al. Relationship between 6-minute walk test and pulmonary function test in stable chronic obstructive pulmonary disease with different severities. Chin. Med. J. 125, 3053–3058 (2012).
van de Bool, C. et al. Muscle quality is more impaired in sarcopenic patients with chronic obstructive pulmonary disease. J. Am. Med. Dir. Assoc. 17, 415–420 (2016).
Cohen, S., Nathan, J. A. & Goldberg, A. L. Muscle wasting in disease: Molecular mechanisms and promising therapies. Nat. Rev. Drug Discov. 14, 58–74 (2015).
MacIntyre, N. R. Muscle dysfunction associated with chronic obstructive pulmonary disease. Respir. Care 51, 840–847 (2006) (discussion 848-852).
Gosker, H. R. et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 19, 617–625 (2002).
Levine, S., Bashir, M. H., Clanton, T. L., Powers, S. K. & Singhal, S. COPD elicits remodeling of the diaphragm and vastus lateralis muscles in humans. J. Appl. Physiol. 1985(114), 1235–1245 (2013).
Sepúlveda-Loyola, W. et al. NOVEL antioxidant and oxidant biomarkers related to sarcopenia in COPD. Heart Lung 50, 184–191 (2021).
Furutate, R. et al. Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease. Int. J. Chronic Obstruct. Pulmon. Dis. 6, 423–430 (2011).
Abbatecola, A. M. et al. Body composition markers in older persons with COPD. Age Ageing 43, 548–553 (2014).
Donahoe, M., Rogers, R. M., Wilson, D. O. & Pennock, B. E. Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 140, 385–391 (1989).
Krzystek-Korpacka, M. et al. Respiratory insufficiency related to COPD accelerates systemic inflammation, under-nutrition, and angiogenesis in esophageal malignancies. Exp. Oncol. 30, 75–80 (2008).
Mete, B., Pehlivan, E., Gülbaş, G. & Günen, H. Prevalence of malnutrition in COPD and its relationship with the parameters related to disease severity. Int. J. Chronic Obstruct Pulmon Dis 13, 3307–3312 (2018).
Ischaki, E. et al. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 132, 164–169 (2007).
Hopkinson, N. S. et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir. Res. 8, 25 (2007).
Mason, S. E. et al. Respiratory exacerbations are associated with muscle loss in current and former smokers. Thorax 76, 554–560 (2021).
Holden, M. et al. Handgrip strength in people with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Phys. Ther. 101, pzab057 (2021).
Chen, L.-K. et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J. Am. Med. Dir. Assoc. 21, 300-307.e2 (2020).
Halpin, D. M. G. et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD Science Committee report on COVID-19 and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 203, 24–36 (2021).
da Lage, V. K. S. et al. Are oxidative stress biomarkers and respiratory muscles strength associated with COPD-related sarcopenia in older adults?. Exp. Gerontol. 157, 111630 (2022).
Gao, J. et al. Resistin as a systemic inflammation-related biomarker for sarcopenia in patients with chronic obstructive pulmonary disease. Front. Nutr. 9, 921399 (2022).
Acknowledgements
This study was supported by the Jiangsu Provincial Medical Key Discipline (ZDXK202201).
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Shen, X., Qian, R., Wei, Y. et al. Prediction model and assessment of malnutrition in patients with stable chronic obstructive pulmonary disease. Sci Rep 14, 6508 (2024). https://doi.org/10.1038/s41598-024-56747-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-56747-2
- Springer Nature Limited